EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimized AAV vector enables potent therapeutic rescue of inherited glycosylphosphatidylinositol deficiency in mice

Saori Umeshita, Kae Imanishi, Shibi Likhite, Mika Ito, Naomi Takino, Kathrin C Meyer, Taroh Kinoshita, Shinichi Muramatsu, Yoshiko Murakami

Molecular Therapy Advances · 2026-06 · 34 (2) · 201724

DOI: 10.1016/j.omta.2026.201724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-06. Verfasst von Saori Umeshita und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunoglycobiology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Japan Agency for Medical Research and Development, Government of Japan Ministry of Health Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AAV-based gene replacement therapyGPI deficiency, IGDPIGOadeno-associated virus, AAVglycosylphosphatidylinositol (GPI)-anchored proteins

Autor:innen und Institutionen

  • Laboratory of Immunoglycobiology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.
  • Center for Gene Therapy, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43215, USA.
  • Division of Neurological Gene Therapy, Jichi Medical University Shimotsuke, Osaka 329-0498, Japan.
  • Department of Pediatrics, The Ohio State University, Columbus, OH 43210, USA.
  • Center for Infectious Disease Education and Research, Osaka University, Suita, Osaka 565-0871, Japan.

Förderung

  • Wellcome Trust
  • Japan Agency for Medical Research and Development
  • Government of Japan Ministry of Health Labour and Welfare
  • Japan Society for the Promotion of Science

Zitieren

APA

Umeshita, S., Imanishi, K., Likhite, S., Ito, M., Takino, N., Meyer, K. C., Kinoshita, T., Muramatsu, S., & Murakami, Y. (2026). Optimized AAV vector enables potent therapeutic rescue of inherited glycosylphosphatidylinositol deficiency in mice. Molecular Therapy Advances, 34(2), 201724. https://doi.org/10.1016/j.omta.2026.201724

Vancouver

Umeshita S, Imanishi K, Likhite S, Ito M, Takino N, Meyer KC, et al. Optimized AAV vector enables potent therapeutic rescue of inherited glycosylphosphatidylinositol deficiency in mice. Molecular Therapy Advances. 2026;34(2):201724. doi:10.1016/j.omta.2026.201724

BibTeX
@article{Umeshita2026,
  author = {Umeshita, Saori and Imanishi, Kae and Likhite, Shibi and Ito, Mika and Takino, Naomi and Meyer, Kathrin C and Kinoshita, Taroh and Muramatsu, Shinichi and Murakami, Yoshiko},
  title = {Optimized AAV vector enables potent therapeutic rescue of inherited glycosylphosphatidylinositol deficiency in mice},
  journal = {Molecular Therapy Advances},
  year = {2026},
  volume = {34},
  number = {2},
  pages = {201724},
  doi = {10.1016/j.omta.2026.201724}
}
Kostenlos starten →